Sam Prince, who received a heart transplant at Columbia at age 8, combines a passion for the New York Giants with his mission to save more lives through organ donation.
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
A common virus that causes no harm in most people may be a danger to organ transplant recipients and other immunocompromised people, Columbia University researchers have found.
A transplant team at NewYork-Presbyterian and Columbia University Vagelos College of Physicians and Surgeons gave a young man with cystic fibrosis new hope with a triple-organ transplant.
Heart transplants, donor hearts, and transplant waitlists all fell sharply at the start of the COVID-19 pandemic in the United States, Columbia University researchers have found.
The health of donated human lungs judged too poor for transplantation can be recovered using a cross-circulation technique designed by biomedical engineers at Columbia University.
Hematopoietic stem cells can survive extraordinary stress. Columbia scientists have learned how they escape death, which could lead to new treatments for blood cancers and diseases related to aging.
Columbia engineers and surgeons show that new salvage methods can recondition severely damaged lungs to meet transplantation criteria and could make more lungs available for patients.
Kidney swaps are spectacular, but Columbia surgeons also practice the art of matching kidneys to patients, which has helped them cut the wait time for a kidney transplant by more than half.
Columbia researchers have discovered that the human intestine has a reservoir of blood-forming stem cells and that the cells play a central role in the success of organ transplantation.